Abstract
Thalassemia gene screening is vital for preventing severe infant morbidity, yet current methods lack the sensitivity for early clinical intervention. Here, we report an enzymatic biofuel cell self-powered biosensor (EBFC-SPB) integrating DNAzyme Walker and dumbbell hybridization chain reaction (DHCR) cascade amplification for attomolar-level detection of TATA-28, a critical thalassemia biomarker. The biosensor employs Au@Zr-MOF/graphdiyne (GDY) as a conductive substrate to immobilize glucose oxidase (bioanode) and [Ru(NH3)6]3+-responsive DNA circuits (biocathode). Target-activated DNAzyme Walker liberates single-stranded DNA (S0), initiating dumbbell HCR to generate electronegative DNA nanostructures that adsorb [Ru(NH3)6]3+. This process drives efficient electron transfer from the bioanode to the biocathode, greatly amplifying the open-circuit voltage (EOCV) compared to non-target conditions. The dual-amplification strategy achieves a linear response from 0.1 fM to 10 nM TATA-28 with a 35.3 aM detection limit (S/N = 3), surpassing existing methods in sensitivity. Successful validation in human serum (recovery: 90.1-106.5 %) highlights its clinical potential for early thalassemia screening.